# TPG Inc.: financial statements, quarterly TPG · Nasdaq · CIK 1880661 · [Financials](/sectors/financials.md) · fiscal year ends Dec 31 Pages: [Overview](/companies/tpg.md) · [Financials](/companies/tpg/financials.md) · [Filings](/companies/tpg/filings.md) · [Insiders](/companies/tpg/insiders.md) Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/tpg/financials.md?period=annual). ## Income statement | Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | | --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | | Revenue | $m | [366](/filings/0001880661-24-000054.md) | [530 d](/filings/0001880661-26-000011.md) | [512](/filings/0001880661-25-000036.md) | [523](/filings/0001880661-25-000063.md) | [525](/filings/0001880661-25-000077.md) | [527 d](/filings/0001880661-26-000011.md) | [543](/filings/0001880661-26-000033.md) | [569](/filings/0001880661-26-000049.md) | [596](/filings/0001880661-25-000077.md) | [715 d](/filings/0001880661-26-000011.md) | [620](/filings/0001880661-26-000033.md) | [705](/filings/0001880661-26-000049.md) | | Income tax | $m | [8.2](/filings/0001880661-24-000054.md) | [26.8 d](/filings/0001880661-26-000011.md) | [4.4](/filings/0001880661-25-000036.md) | [22.4](/filings/0001880661-25-000063.md) | [13.9](/filings/0001880661-25-000077.md) | [11.4 d](/filings/0001880661-26-000011.md) | [6.3](/filings/0001880661-26-000033.md) | [9.2](/filings/0001880661-26-000049.md) | [28.9](/filings/0001880661-25-000077.md) | [22.5 d](/filings/0001880661-26-000011.md) | [(17.4)](/filings/0001880661-26-000033.md) | [36.3](/filings/0001880661-26-000049.md) | | Net income | $m | [14.7](/filings/0001880661-24-000054.md) | [13.2 d](/filings/0001880661-26-000011.md) | [15.5](/filings/0001880661-25-000036.md) | [(14.0)](/filings/0001880661-25-000063.md) | [9.0](/filings/0001880661-25-000077.md) | [13.0 d](/filings/0001880661-26-000011.md) | [25.4](/filings/0001880661-26-000033.md) | [14.9](/filings/0001880661-26-000049.md) | [67.1](/filings/0001880661-25-000077.md) | [77.1 d](/filings/0001880661-26-000011.md) | [(1.5)](/filings/0001880661-26-000033.md) | [93.4](/filings/0001880661-26-000049.md) | | Diluted EPS | $ per share | [(0.09)](/filings/0001880661-24-000054.md) | not reported | [(0.11)](/filings/0001880661-25-000036.md) | [(0.19)](/filings/0001880661-25-000063.md) | [(0.08)](/filings/0001880661-25-000077.md) | not reported | [0.00](/filings/0001880661-26-000033.md) | [(0.05)](/filings/0001880661-26-000049.md) | [0.20](/filings/0001880661-25-000077.md) | not reported | [(0.22)](/filings/0001880661-26-000033.md) | [0.39](/filings/0001880661-26-000049.md) | | Basic EPS | $ per share | [0.14](/filings/0001880661-24-000054.md) | not reported | [0.09](/filings/0001880661-25-000036.md) | [(0.15)](/filings/0001880661-25-000063.md) | [0.04](/filings/0001880661-25-000077.md) | not reported | [0.08](/filings/0001880661-26-000033.md) | [0.03](/filings/0001880661-26-000049.md) | [0.33](/filings/0001880661-25-000077.md) | not reported | [(0.05)](/filings/0001880661-26-000033.md) | [0.44](/filings/0001880661-26-000049.md) | - Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax - Income tax: us-gaap:IncomeTaxExpenseBenefit - Net income: us-gaap:NetIncomeLoss - Diluted EPS: us-gaap:EarningsPerShareDiluted - Basic EPS: us-gaap:EarningsPerShareBasic ## Balance sheet | Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | | --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | | Cash and equivalents | $bn | [1.2](/filings/0001880661-24-000054.md) | [0.7](/filings/0001880661-26-000011.md) | [1.1](/filings/0001880661-25-000036.md) | [1.1](/filings/0001880661-25-000063.md) | [1.2](/filings/0001880661-25-000077.md) | [0.8](/filings/0001880661-26-000011.md) | [0.8](/filings/0001880661-26-000033.md) | [1.1](/filings/0001880661-26-000049.md) | [1.1](/filings/0001880661-25-000077.md) | [0.8](/filings/0001880661-26-000049.md) | [0.9](/filings/0001880661-26-000033.md) | [0.9](/filings/0001880661-26-000049.md) | | Total assets | $bn | [7.4](/filings/0001880661-23-000106.md) | [9.4](/filings/0001880661-25-000014.md) | [9.9](/filings/0001880661-24-000032.md) | [10.1](/filings/0001880661-24-000044.md) | [10.5](/filings/0001880661-24-000054.md) | [10.5](/filings/0001880661-26-000011.md) | [11.3](/filings/0001880661-25-000036.md) | [12.0](/filings/0001880661-25-000063.md) | [13.0](/filings/0001880661-25-000077.md) | [13.5](/filings/0001880661-26-000049.md) | [13.3](/filings/0001880661-26-000033.md) | [14.0](/filings/0001880661-26-000049.md) | | Total liabilities | $bn | [4.3](/filings/0001880661-23-000106.md) | [6.0](/filings/0001880661-25-000014.md) | [6.6](/filings/0001880661-24-000032.md) | [6.8](/filings/0001880661-24-000044.md) | [7.1](/filings/0001880661-24-000054.md) | [6.9](/filings/0001880661-26-000011.md) | [7.8](/filings/0001880661-25-000036.md) | [8.4](/filings/0001880661-25-000063.md) | [9.2](/filings/0001880661-25-000077.md) | [9.4](/filings/0001880661-26-000049.md) | [9.6](/filings/0001880661-26-000033.md) | [10.3](/filings/0001880661-26-000049.md) | | Long-term debt | $bn | [0.4](/filings/0001880661-23-000106.md) | [0.9](/filings/0001880661-25-000014.md) | [1.2](/filings/0001880661-24-000032.md) | [1.2](/filings/0001880661-24-000044.md) | [1.3](/filings/0001880661-24-000054.md) | [1.3](/filings/0001880661-26-000011.md) | [1.5](/filings/0001880661-25-000036.md) | [1.6](/filings/0001880661-25-000063.md) | [1.8](/filings/0001880661-25-000077.md) | [1.7](/filings/0001880661-26-000049.md) | [2.3](/filings/0001880661-26-000033.md) | [2.3](/filings/0001880661-26-000049.md) | | Shareholders' equity | $bn | [3.0](/filings/0001880661-24-000054.md) | [3.4](/filings/0001880661-26-000011.md) | [3.3](/filings/0001880661-25-000063.md) | [3.3](/filings/0001880661-25-000077.md) | [3.4](/filings/0001880661-25-000077.md) | [3.6](/filings/0001880661-26-000049.md) | [3.5](/filings/0001880661-26-000049.md) | [3.6](/filings/0001880661-26-000049.md) | [3.8](/filings/0001880661-25-000077.md) | [4.1](/filings/0001880661-26-000049.md) | [3.7](/filings/0001880661-26-000049.md) | [3.7](/filings/0001880661-26-000049.md) | - Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue - Total assets: us-gaap:Assets - Total liabilities: us-gaap:Liabilities - Long-term debt: us-gaap:LongTermDebt - Shareholders' equity: us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest ## Cash flow | Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | | --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | | Operating cash flow | $m | [692 d](/filings/0001880661-24-000054.md) | [(512) d](/filings/0001880661-26-000011.md) | [437](/filings/0001880661-25-000036.md) | [215 d](/filings/0001880661-25-000063.md) | [68.9 d](/filings/0001880661-25-000077.md) | [(188) d](/filings/0001880661-26-000011.md) | [198](/filings/0001880661-26-000033.md) | [386 d](/filings/0001880661-26-000049.md) | [492 d](/filings/0001880661-25-000077.md) | [(43.7) d](/filings/0001880661-26-000011.md) | [177](/filings/0001880661-26-000033.md) | [348 d](/filings/0001880661-26-000049.md) | - Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities ## Shares | Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | | --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | | Diluted shares (weighted) | millions of shares | [309](/filings/0001880661-23-000106.md) | [309](/filings/0001880661-24-000032.md) | [309](/filings/0001880661-24-000044.md) | [309](/filings/0001880661-24-000054.md) | [364](/filings/0001880661-25-000036.md) | [365](/filings/0001880661-25-000063.md) | [365](/filings/0001880661-25-000077.md) | [369](/filings/0001880661-26-000033.md) | [370](/filings/0001880661-26-000049.md) | [378](/filings/0001880661-25-000077.md) | [384](/filings/0001880661-26-000033.md) | [385](/filings/0001880661-26-000049.md) | - Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:49 ET. No prices; not investment advice.